Contrast-Enhanced Spectral Mammography is Comparable to MRI in the Assessment of Residual Breast Cancer Following Neoadjuvant Systemic Therapy

Bhavika K. Patel, Talal Hilal, Matthew Covington, Nan Zhang, Heidi E. Kosiorek, Marc Lobbes, Donald W. Northfelt, Barbara A. Pockaj

Research output: Contribution to journalArticlepeer-review

40 Scopus citations

Fingerprint

Dive into the research topics of 'Contrast-Enhanced Spectral Mammography is Comparable to MRI in the Assessment of Residual Breast Cancer Following Neoadjuvant Systemic Therapy'. Together they form a unique fingerprint.

Medicine & Life Sciences